Type III secretion system

Last updated
A transmission electron microscope image of isolated T3SS needle complexes from Salmonella typhimurium TEM of isolated T3SS needle complexes.jpg
A transmission electron microscope image of isolated T3SS needle complexes from Salmonella typhimurium

The type III secretion system (T3SS or TTSS) is one of the bacterial secretion systems used by bacteria to secrete their effector proteins into the host's cells to promote virulence and colonisation. [1] [2] While the type III secretion system has been widely regarded as equivalent to the injectisome, many argue that the injectisome is only part of the type III secretion system, which also include structures like the flagellar export apparatus. [3] The T3SS is a needle-like protein complex found in several species of pathogenic gram-negative bacteria.

Contents

Overview

The term Type III secretion system was coined in 1993. [4] This secretion system is distinguished from at least five other secretion systems found in gram-negative bacteria. Many animal and plant associated bacteria possess similar T3SSs. These T3SSs are similar as a result of convergent evolution and phylogenetic analysis supports a model in which gram-negative bacteria can transfer the T3SS gene cassette horizontally to other species. Some of the most researched T3SSs are from species of:[ citation needed ]

The T3SS is composed of approximately 30 different proteins, making it one of the most complex secretion systems. Its structure shows many similarities with bacterial flagella (long, rigid, extracellular structures used for motility). Some of the proteins participating in T3SS share amino-acid sequence homology to flagellar proteins. Some of the bacteria possessing a T3SS have flagella as well and are motile (Salmonella, for instance), and some do not (Shigella, for instance). Technically speaking, type III secretion is used both for secreting infection-related proteins and flagellar components. However, the term "type III secretion" is used mainly in relation to the infection apparatus. The bacterial flagellum shares a common ancestor with the type III secretion system. [5] [6]

T3SSs are essential for the pathogenicity (the ability to infect) of many pathogenic bacteria. Defects in the T3SS may render a bacterium non-pathogenic. It has been suggested that some non-invasive strains of gram-negative bacteria have lost the T3SS because the energetically costly system is no longer of use. [7] Although traditional antibiotics were effective against these bacteria in the past, antibiotic-resistant strains constantly emerge. Understanding the way the T3SS works and developing drugs targeting it specifically have become an important goal of many research groups around the world since the late 1990s.

Structure

Type III secretion system
T3SS needle complex.svg
The T3SS needle complex
Identifiers
SymbolT3SS
TCDB 1.B.22
OPM superfamily 348
OPM protein 5tcq

The hallmark of T3SS is the needle [8] [9] (more generally, the needle complex (NC) or the T3SS apparatus (T3SA); also called injectisome when the ATPase is excluded; see below). Bacterial proteins that need to be secreted pass from the bacterial cytoplasm through the needle directly into the host cytoplasm. Three membranes separate the two cytoplasms: the double membranes (inner and outer membranes) of the Gram-negative bacterium and the eukaryotic membrane. The needle provides a smooth passage through those highly selective and almost impermeable membranes. A single bacterium can have several hundred needle complexes spread across its membrane. It has been proposed that the needle complex is a universal feature of all T3SSs of pathogenic bacteria. [10]

The needle complex starts at the cytoplasm of the bacterium, crosses the two membranes and protrudes from the cell. The part anchored in the membrane is the base (or basal body) of the T3SS. The extracellular part is the needle. A so-called inner rod connects the needle to the base. The needle itself, although the biggest and most prominent part of the T3SS, is made out of many units of a single protein. The majority of the different T3SS proteins are therefore those that build the base and those that are secreted into the host. As mentioned above, the needle complex shares similarities with bacterial flagella. More specifically, the base of the needle complex is structurally very similar to the flagellar base; the needle itself is analogous to the flagellar hook, a structure connecting the base to the flagellar filament. [11] [12]

The base is composed of several circular rings and is the first structure that is built in a new needle complex. Once the base is completed, it serves as a secretion machine for the outer proteins (the needle). Once the whole complex is completed the system switches to secreting proteins that are intended to be delivered into host cells. The needle is presumed to be built from bottom to top; units of needle monomer protein pile upon each other, so that the unit at the tip of the needle is the last one added. The needle subunit is one of the smallest T3SS proteins, measuring at around 9 kDa. 100−150 subunits comprise each needle.

The T3SS needle measures around 60−80 nm in length and 8 nm in external width. It needs to have a minimal length so that other extracellular bacterial structures (adhesins and the lipopolysaccharide layer, for instance) do not interfere with secretion. The hole of the needle has a 3 nm diameter. Most folded effector proteins are too large to pass through the needle opening, so most secreted proteins must pass through the needle unfolded, a task carried out by the ATPase at the base of the structure. [13]

T3SS proteins

Diagram of individual substructures of the needle complex from Salmonella typhimurium Basal body of T3SS needle complex.jpg
Diagram of individual substructures of the needle complex from Salmonella typhimurium

The T3SS proteins can be grouped into three categories:

Most T3SS genes are laid out in operons. These operons are located on the bacterial chromosome in some species and on a dedicated plasmid in other species. Salmonella, for instance, has a chromosomal region in which most T3SS genes are gathered, the so-called Salmonellapathogenicity island (SPI). Shigella, on the other hand, has a large virulence plasmid on which all T3SS genes reside. It is important to note that many pathogenicity islands and plasmids contain elements that allow for frequent horizontal gene transfer of the island/plasmid to a new species.

Effector proteins that are to be secreted through the needle need to be recognized by the system, since they float in the cytoplasm together with thousands of other proteins. Recognition is done through a secretion signal—a short sequence of amino acids located at the beginning (the N-terminus) of the protein (usually within the first 20 amino acids), that the needle complex is able to recognize. Unlike other secretion systems, the secretion signal of T3SS proteins is never cleaved off the protein.

Induction of secretion

Contact of the needle with a host cell triggers the T3SS to start secreting; [14] not much is known about this trigger mechanism (see below). Secretion can also be induced by lowering the concentration of calcium ions in the growth medium (for Yersinia and Pseudomonas; done by adding a chelator such as EDTA or EGTA) and by adding the aromatic dye Congo red to the growth medium (for Shigella), for instance. These methods and other are used in laboratories to artificially induce type III secretion.

Induction of secretion by external cues other than contact with host cells also takes place in vivo , in infected organisms. The bacteria sense such cues as temperature, pH, osmolarity and oxygen levels, and use them to "decide" whether to activate their T3SS. For instance, Salmonella can replicate and invade better in the ileum rather than in the cecum of animal intestine. The bacteria are able to know where they are thanks to the different ions present in these regions; the ileum contains formate and acetate, while the cecum does not. The bacteria sense these molecules, determine that they are at the ileum and activate their secretion machinery. Molecules present in the cecum, such as propionate and butyrate, provide a negative cue to the bacteria and inhibit secretion. Cholesterol, a lipid found in most eukaryotic cell membranes, is able to induce secretion in Shigella.

The external cues listed above either regulate secretion directly or through a genetic mechanism. Several transcription factors that regulate the expression of T3SS genes are known. Some of the chaperones that bind T3SS effectors also act as transcription factors. A feedback mechanism has been suggested: when the bacterium does not secrete, its effector proteins are bound to chaperones and float in the cytoplasm. When secretion starts, the chaperones detach from the effectors and the latter are secreted and leave the cell. The lone chaperones then act as transcription factors, binding to the genes encoding their effectors and inducing their transcription and thereby the production of more effectors.

Structures similar to Type3SS injectisomes have been proposed to rivet gram negative bacterial outer and inner membranes to help release outer membrane vesicles targeted to deliver bacterial secretions to eukaryotic host or other target cells in vivo. [15]

T3SS-mediated infection

T3SS effectors enter the needle complex at the base and make their way inside the needle towards the host cell. The exact way in which effectors enter the host is mostly unknown. It has been previously suggested that the needle itself is capable of puncturing a hole in the host cell membrane; this theory has been refuted. It is now clear that some effectors, collectively named translocators, are secreted first and produce a pore or a channel (a translocon) in the host cell membrane, through which other effectors may enter. Mutated bacteria that lack translocators are able to secrete proteins but are not able to deliver them into host cells. In general each T3SS includes three translocators. Some translocators serve a double role; after they participate in pore formation they enter the cell and act as bona fide effectors.

T3SS effectors manipulate host cells in several ways. The most striking effect is the promoting of uptake of the bacterium by the host cell. Many bacteria possessing T3SSs must enter host cells in order to replicate and propagate infection. The effectors they inject into the host cell induce the host to engulf the bacterium and to practically "eat" it. In order for this to happen the bacterial effectors manipulate the actin polymerization machinery of the host cell. Actin is a component of the cytoskeleton and it also participates in motility and in changes in cell shape. Through its T3SS effectors the bacterium is able to utilize the host cell's own machinery for its own benefit. Once the bacterium has entered the cell it is able to secrete other effectors more easily and it can penetrate neighboring cells and quickly infect the whole tissue.

T3SS effectors have also been shown to tamper with the host's cell cycle and some of them are able to induce apoptosis. One of the most researched T3SS effector is IpaB from Shigella flexneri . It serves a double role, both as a translocator, creating a pore in the host cell membrane, and as an effector, exerting multiple detrimental effects on the host cell. It had been demonstrated that IpaB induces apoptosis in macrophages—cells of the animal immune system—after being engulfed by them. [16] It was later shown that IpaB achieves this by interacting with caspase 1, a major regulatory protein in eukaryotic cells. [17]

Another well characterized class of T3SS effectors are Transcription Activator-like effectors (TAL effectors) from Xanthomonas. When injected into plants, these proteins can enter the nucleus of the plant cell, bind plant promoter sequences, and activate transcription of plant genes that aid in bacterial infection. [18] TAL effector-DNA recognition has recently been demonstrated to comprise a simple code [19] [20] and this has greatly improved the understanding of how these proteins can alter the transcription of genes in the host plant cells.

Unresolved issues

The topology and organization of the Salmonella needle complex. Topology of T3SS needle complex.jpg
The topology and organization of the Salmonella needle complex.

Hundreds of articles on T3SS have been published since the mid-nineties. However, numerous issues regarding the system remain unresolved:

Nomenclature of T3SS proteins

Flagellum of Gram-negative bacteria. The rings of the base are very similar to needle-complex rings, although the existence of a C-ring in the needle complex has not been proven. The flagellar hook is homologous to the T3SS needle Flagellum base diagram-en.svg
Flagellum of Gram-negative bacteria. The rings of the base are very similar to needle-complex rings, although the existence of a C-ring in the needle complex has not been proven. The flagellar hook is homologous to the T3SS needle

Since the beginning of the 1990s new T3SS proteins are being found in different bacterial species at a steady rate. Abbreviations have been given independently for each series of proteins in each organism, and the names usually do not reveal much about the protein's function. Some proteins discovered independently in different bacteria have later been shown to be homologous; the historical names, however, have mostly been kept, a fact that might cause confusion. For example, the proteins SicA, IpgC and SycD are homologs from Salmonella, Shigella and Yersinia, respectively, but the last letter (the "serial number") in their name does not show that.

Below is a summary of the most common protein-series names in several T3SS-containing species. Note that these names include proteins that form the T3SS machinery as well as the secreted effector proteins:

Following those abbreviations is a letter or a number. Letters usually denote a "serial number", either the chronological order of discovery or the physical order of appearance of the gene in an operon. Numbers, the rarer case, denote the molecular weight of the protein in kDa. Examples: IpaA, IpaB, IpaC; MxiH, MxiG, MxiM; Spa9, Spa47.

Several key elements appear in all T3SSs: the needle monomer, the inner rod of the needle, the ring proteins, the two translocators, the needle-tip protein, the ruler protein (which is thought to determine the needle's length; see above) and the ATPase, which supplies energy for secretion. The following table shows some of these key proteins in four T3SS-containing bacteria:

↓ Function / Genus →ShigellaSalmonellaYersiniaEscherichia
Needle monomerMxiHPrgIYscFEscF
Inner rodMxiIPrgJYscIEscI
Needle-tip proteinIpaDSipDLcrVEspA
TranslocatorIpaBSipBYopBEspD
TranslocatorIpaCSipCYopDEspB
Chaperone for the two translocatorsIpgCSicASycDCesD
ATPaseSpa47InvCYscNSepB (EscN)
Ruler proteinSpa32InvJYscPOrf16
SwitchSpa40SpaSYscUEscU
GatekeeperMxiCInvEYopN (TyeA)SepL

Methods employed in T3SS research

Isolation of T3SS needle complexes

The isolation of large, fragile, hydrophobic membrane structures from cells has constituted a challenge for many years. By the end of the 1990s, however, several approaches have been developed for the isolation of T3SS NCs. In 1998 the first NCs were isolated from Salmonella typhimurium . [29]

For the isolation, bacteria are grown in a large volume of liquid growth medium until they reach log phase. They are then centrifuged; the supernatant (the medium) is discarded and the pellet (the bacteria) is resuspended in a lysis buffer typically containing lysozyme and sometimes a detergent such as LDAO or Triton X-100. This buffer disintegrates the cell wall. After several rounds of lysis and washing, the opened bacteria are subjected to a series of ultracentrifugations. This treatment enriches large macromolecular structures and discards smaller cell components. Optionally, the final lysate is subjected to further purification by CsCl density gradient.

An additional approach for further purification uses affinity chromatography. Recombinant T3SS proteins that carry a protein tag (a histidine tag, for instance) are produced by molecular cloning and then introduced (transformed) into the researched bacteria. After initial NC isolation, as described above, the lysate is passed through a column coated with particles with high affinity to the tag (in the case of histidine tags: nickel ions). The tagged protein is retained in the column, and with it the entire needle complex. High degrees of purity can be achieved using such methods. This purity is essential for many delicate assays that have been used for NC characterization.

Type III effectors were known since the beginning of the 1990s, but the way in which they are delivered into host cells was a complete mystery. The homology between many flagellar and T3SS proteins led researchers to suspects the existence of an outer T3SS structure similar to flagella. The identification and subsequent isolation of the needle structure enabled researchers to:

Microscopy, crystallography and solid-state NMR

As with almost all proteins, the visualization of T3SS NCs is only possible with electron microscopy. The first images of NCs (1998) showed needle structures protruding from the cell wall of live bacteria and flat, two-dimensional isolated NCs. [29] In 2001 images of NCs from Shigella flexneri were digitally analyzed and averaged to obtain a first semi-3D structure of the NC. [8] The helical structure of NCs from Shigella flexneri was resolved at a resolution of 16 Å using X-ray fiber diffraction in 2003, [30] and a year later a 17-Å 3D structure of NCs from Salmonella typhimurium was published. [31] Recent advances and approaches have allowed high-resolution 3D images of the NC, [32] [33] further clarifying the complex structure of the NC.

Numerous T3SS proteins have been crystallized over the years. These include structural proteins of the NC, effectors and chaperones. The first structure of a needle-complex monomer was NMR structure of BsaL from "Burkholderia pseudomallei" and later the crystal structure of MixH from Shigella flexneri, which were both resolved in 2006. [34] [35]

In 2012, a combination of recombinant wild-type needle production, solid-state NMR, electron microscopy [36] and Rosetta modeling revealed the supramolecular interfaces and ultimately the complete atomic structure of the Salmonella typhimurium T3SS needle. [37] It was shown that the 80-residue PrgI subunits form a right-handed helical assembly with roughly 11 subunits per two turns, similar to that of the flagellum of Salmonella typhimurium . The model also revealed an extended amino-terminal domain that is positioned on the surface of the needle, while the highly conserved carboxy terminus points towards the lumen. [37]

Proteomics

Several methods have been employed in order to identify the array of proteins that comprise the T3SS. Isolated needle complexes can be separated with SDS-PAGE. The bands that appear after staining can be individually excised from the gel and analyzed using protein sequencing and mass spectrometry. The structural components of the NC can be separated from each other (the needle part from the base part, for instance), and by analyzing those fractions the proteins participating in each one can be deduced. Alternatively, isolated NCs can be directly analyzed by mass spectrometry, without prior electrophoresis, in order to obtain a complete picture of the NC proteome.

Genetic and functional studies

The T3SS in many bacteria has been manipulated by researchers. Observing the influence of individual manipulations can be used to draw insights into the role of each component of the system. Examples of manipulations are:

Manipulation of T3SS components can have influence on several aspects of bacterial function and pathogenicity. Examples of possible influences:

Inhibitors of the T3SS

A few compounds have been discovered that inhibit the T3SS in gram-negative bacteria, including the guadinomines which are naturally produced by Streptomyces species. [38] Monoclonal antibodies have been developed that inhibit the T3SS too. [39] Aurodox, an antibiotic capable of inhibiting the translation of T3SS proteins has been shown to able to prevent T3SS effectors in vitro and in animal models [40] [41]

Type III signal peptide prediction tools

Related Research Articles

<span class="mw-page-title-main">Flagellum</span> Cellular appendage functioning as locomotive or sensory organelle

A flagellum is a hairlike appendage that protrudes from certain plant and animal sperm cells, from fungal spores (zoospores), and from a wide range of microorganisms to provide motility. Many protists with flagella are known as flagellates.

<span class="mw-page-title-main">Secretion</span> Controlled release of substances by cells or tissues

Secretion is the movement of material from one point to another, such as a secreted chemical substance from a cell or gland. In contrast, excretion is the removal of certain substances or waste products from a cell or organism. The classical mechanism of cell secretion is via secretory portals at the plasma membrane called porosomes. Porosomes are permanent cup-shaped lipoprotein structures embedded in the cell membrane, where secretory vesicles transiently dock and fuse to release intra-vesicular contents from the cell.

<i>Shigella flexneri</i> Species of bacterium

Shigella flexneri is a species of Gram-negative bacteria in the genus Shigella that can cause diarrhea in humans. Several different serogroups of Shigella are described; S. flexneri belongs to group B. S. flexneri infections can usually be treated with antibiotics, although some strains have become resistant. Less severe cases are not usually treated because they become more resistant in the future. Shigella are closely related to Escherichia coli, but can be differentiated from E.coli based on pathogenicity, physiology and serology.

<i>Yersinia pseudotuberculosis</i> Species of bacterium

Yersinia pseudotuberculosis is a Gram-negative bacterium that causes Far East scarlet-like fever in humans, who occasionally get infected zoonotically, most often through the food-borne route. Animals are also infected by Y. pseudotuberculosis. The bacterium is urease positive.

Virulence factors are cellular structures, molecules and regulatory systems that enable microbial pathogens to achieve the following:

<i>Ralstonia solanacearum</i> Disease bacteria of tomato family, others

Ralstonia solanacearum is an aerobic non-spore-forming, Gram-negative, plant pathogenic bacterium. R. solanacearum is soil-borne and motile with a polar flagellar tuft. It colonises the xylem, causing bacterial wilt in a very wide range of potential host plants. It is known as Granville wilt when it occurs in tobacco. Bacterial wilts of tomato, pepper, eggplant, and Irish potato caused by R. solanacearum were among the first diseases that Erwin Frink Smith proved to be caused by a bacterial pathogen. Because of its devastating lethality, R. solanacearum is now one of the more intensively studied phytopathogenic bacteria, and bacterial wilt of tomato is a model system for investigating mechanisms of pathogenesis. Ralstonia was until recently classified as Pseudomonas, with similarity in most aspects, except that it does not produce fluorescent pigment like Pseudomonas. The genomes from different strains vary from 5.5 Mb up to 6 Mb, roughly being 3.5 Mb of a chromosome and 2 Mb of a megaplasmid. While the strain GMI1000 was one of the first phytopathogenic bacteria to have its genome completed, the strain UY031 was the first R. solanacearum to have its methylome reported. Within the R. solanacearum species complex, the four major monophyletic clusters of strains are termed phylotypes, that are geographically distinct: phylotypes I-IV are found in Asia, the Americas, Africa, and Oceania, respectively.

<span class="mw-page-title-main">LcrV</span>

In molecular biology, LcrV is a protein found in Yersinia pestis and several other bacterial species. It forms part of the Yersinia pestis virulence protein factors that also includes all Yops, or Yersinia outer protein, but the name has been kept out of convention. LcrV's main function is not actually known, but it is essential for the production of other Yops.

Omptins are a family of bacterial proteases. They are aspartate proteases, which cleave peptides with the use of a water molecule. Found in the outer membrane of gram-negative enterobacteria such as Shigella flexneri, Yersinia pestis, Escherichia coli, and Salmonella enterica. Omptins consist of a widely conserved beta barrel spanning the membrane with 5 extracellular loops. These loops are responsible for the various substrate specificities. These proteases rely upon binding of lipopolysaccharide for activity.

Interspecies quorum sensing is a type of quorum sensing in which bacteria send and receive signals to other species besides their own. This is accomplished by the secretion of signaling molecules which trigger a response in nearby bacteria at high enough concentrations. Once the molecule hits a certain concentration it triggers the transcription of certain genes such as virulence factors. It has been discovered that bacteria can not only interact via quorum sensing with members of their own species but that there is a kind of universal molecule that allows them to gather information about other species as well. This universal molecule is called autoinducer 2 or AI-2.

<span class="mw-page-title-main">YopR bacterial protein domain</span>

In molecular biology, YopR is a protein domain commonly found in gram negative bacteria, in particular Yersinia and is a core domain. Proteins in this entry are type III secretion system effectors. They are named differently in different species and in Yersinia has been designated YopR which is encoded by the YscH gene. This Yop protein is unusual in that it is released to the extracellular environment rather than injected directly into the target cell as are most Yop proteins. A hallmark of Yersinia type III machines is the presence of needles extending from the bacterial surface. Needles perform two functions, firstly, as a channel to export effectors into the immune cells and secondly as a sensor.

Jorge Enrique Galán is an Argentinian-American microbiologist who specializes in infectious disease, bacterial pathogenesis including Salmonella.

Bacterial effectors are proteins secreted by pathogenic bacteria into the cells of their host, usually using a type 3 secretion system (TTSS/T3SS), a type 4 secretion system (TFSS/T4SS) or a Type VI secretion system (T6SS). Some bacteria inject only a few effectors into their host’s cells while others may inject dozens or even hundreds. Effector proteins may have many different activities, but usually help the pathogen to invade host tissue, suppress its immune system, or otherwise help the pathogen to survive. Effector proteins are usually critical for virulence. For instance, in the causative agent of plague, the loss of the T3SS is sufficient to render the bacteria completely avirulent, even when they are directly introduced into the bloodstream. Gram negative microbes are also suspected to deploy bacterial outer membrane vesicles to translocate effector proteins and virulence factors via a membrane vesicle trafficking secretory pathway, in order to modify their environment or attack/invade target cells, for example, at the host-pathogen interface.

Membrane vesicle trafficking in eukaryotic animal cells involves movement of biochemical signal molecules from synthesis-and-packaging locations in the Golgi body to specific release locations on the inside of the plasma membrane of the secretory cell. It takes place in the form of Golgi membrane-bound micro-sized vesicles, termed membrane vesicles (MVs).

The type VI secretion system (T6SS) is molecular machine used by a wide range of Gram-negative bacterial species to transport effectors from the interior of a bacterial cell across the cellular envelope into an adjacent target cell. While often reported that the T6SS was discovered in 2006 by researchers studying the causative agent of cholera, Vibrio cholerae, the first study demonstrating that T6SS genes encode a protein export apparatus was actually published in 2004, in a study of protein secretion by the fish pathogen Edwardsiella tarda.

The type 2 secretion system is a type of protein secretion machinery found in various species of Gram-negative bacteria, including many human pathogens such as Pseudomonas aeruginosa and Vibrio cholerae. The type II secretion system is one of six protein secretory systems commonly found in Gram-negative bacteria, along with the type I, type III, and type IV secretion systems, as well as the chaperone/usher pathway, the autotransporter pathway/type V secretion system, and the type VI secretion system. Like these other systems, the type II secretion system enables the transport of cytoplasmic proteins across the lipid bilayers that make up the cell membranes of Gram-negative bacteria. Secretion of proteins and effector molecules out of the cell plays a critical role in signaling other cells and in the invasion and parasitism of host cells.

Contact-dependent growth inhibition (CDI) is a phenomenon where a bacterial cell may deliver a polymorphic toxin molecule into neighbouring bacterial cells upon direct cell-cell contact, causing growth arrest or cell death.

<span class="mw-page-title-main">Bacterial secretion system</span> Protein complexes present on the cell membranes of bacteria for secretion of substances

Bacterial secretion systems are protein complexes present on the cell membranes of bacteria for secretion of substances. Specifically, they are the cellular devices used by pathogenic bacteria to secrete their virulence factors to invade the host cells. They can be classified into different types based on their specific structure, composition and activity. Generally, proteins can be secreted through two different processes. One process is a one-step mechanism in which proteins from the cytoplasm of bacteria are transported and delivered directly through the cell membrane into the host cell. Another involves a two-step activity in which the proteins are first transported out of the inner cell membrane, then deposited in the periplasm, and finally through the outer cell membrane into the host cell.

<span class="mw-page-title-main">Nucleomodulin</span>

Nucleomodulins are a family of bacterial proteins that enter the nucleus of eukaryotic cells.

Parvulin-like peptidyl-prolyl isomerase (PrsA), also referred to as putative proteinase maturation protein A (PpmA), functions as a molecular chaperone in Gram-positive bacteria, such as B. subtilis, S. aureus, L. monocytogenes and S. pyogenes. PrsA proteins contain a highly conserved parvulin domain that contains peptidyl-prolyl cis-trans isomerase (PPIase) activity capable of catalyzing the bond N-terminal to proline from cis to trans, or vice versa, which is a rate limiting step in protein folding. PrsA homologs also contain a foldase domain suspected to aid in the folding of proteins but, unlike the parvulin domain, is not highly conserved. PrsA proteins are capable of forming multimers in vivo and in vitro and, when dimerized, form a claw-like structure linked by the NC domains. Most Gram-positive bacteria contain only one PrsA-like protein, but some organisms such as L. monocytogenes, B. anthracis and S. pyogenes contain two PrsAs.

Type VII secretion systems are bacterial secretion systems first observed in the phyla Actinomycetota and Bacillota. Bacteria use such systems to transport, or secrete, proteins into the environment. The bacterial genus Mycobacterium uses type VII secretion systems (T7SS) to secrete proteins across their cell envelope. The first T7SS system discovered was the ESX-1 System.

References

  1. ↑ Lara-Tejero M, Galán JE (March 2019). "The Injectisome, a Complex Nanomachine for Protein Injection into Mammalian Cells". EcoSal Plus. 8 (2). doi:10.1128/ecosalplus.ESP-0039-2018. PMC   6450406 . PMID   30942149.
  2. ↑ McHugh RE, O'Boyle N, Connolly JP, Hoskisson PA, Roe AJ (February 2019). "Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis". Infection and Immunity. 87 (2): e00595–18. doi:10.1128/IAI.00595-18. PMC   6346137 . PMID   30455200.
  3. ↑ Halte M, Erhardt M (January 2021). "Protein Export via the Type III Secretion System of the Bacterial Flagellum". Biomolecules. 11 (2): 186. doi: 10.3390/biom11020186 . PMC   7911332 . PMID   33572887.
  4. ↑ Salmond GP, Reeves PJ (January 1993). "Membrane traffic wardens and protein secretion in gram-negative bacteria". Trends in Biochemical Sciences. 18 (1): 7–12. doi:10.1016/0968-0004(93)90080-7. PMID   8438237.
  5. 1 2 Gophna U, Ron EZ, Graur D (July 2003). "Bacterial type III secretion systems are ancient and evolved by multiple horizontal-transfer events". Gene. 312: 151–163. doi:10.1016/S0378-1119(03)00612-7. PMID   12909351.
  6. ↑ Nguyen L, Paulsen IT, Tchieu J, Hueck CJ, Saier MH (April 2000). "Phylogenetic analyses of the constituents of Type III protein secretion systems". Journal of Molecular Microbiology and Biotechnology. 2 (2): 125–144. PMID   10939240.
  7. ↑ Gong H, Vu GP, Bai Y, Yang E, Liu F, Lu S (January 2010). "Differential expression of Salmonella type III secretion system factors InvJ, PrgJ, SipC, SipD, SopA and SopB in cultures and in mice". Microbiology. 156 (Pt 1): 116–127. doi: 10.1099/mic.0.032318-0 . PMC   2889428 . PMID   19762438.
  8. 1 2 Blocker A, Jouihri N, Larquet E, Gounon P, Ebel F, Parsot C, et al. (February 2001). "Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton". Molecular Microbiology. 39 (3): 652–663. doi: 10.1046/j.1365-2958.2001.02200.x . PMID   11169106.
  9. ↑ Galán JE, Wolf-Watz H (November 2006). "Protein delivery into eukaryotic cells by type III secretion machines". Nature. 444 (7119): 567–573. Bibcode:2006Natur.444..567G. doi:10.1038/nature05272. PMID   17136086. S2CID   4411244.
  10. ↑ Pallen MJ, Bailey CM, Beatson SA (April 2006). "Evolutionary links between FliH/YscL-like proteins from bacterial type III secretion systems and second-stalk components of the FoF1 and vacuolar ATPases". Protein Science. 15 (4): 935–941. doi:10.1110/ps.051958806. PMC   2242474 . PMID   16522800.
  11. ↑ Aizawa SI (August 2001). "Bacterial flagella and type III secretion systems". FEMS Microbiology Letters. 202 (2): 157–164. doi: 10.1111/j.1574-6968.2001.tb10797.x . PMID   11520608.
  12. ↑ Doolittle WF, Zhaxybayeva O (July 2007). "Evolution: reducible complexity -- the case for bacterial flagella". Current Biology. 17 (13): R510–R512. Bibcode:2007CBio...17.R510D. doi: 10.1016/j.cub.2007.05.003 . PMID   17610831. S2CID   17452659.
  13. ↑ Akeda Y, Galán JE (October 2005). "Chaperone release and unfolding of substrates in type III secretion". Nature. 437 (7060): 911–915. Bibcode:2005Natur.437..911A. doi:10.1038/nature03992. PMID   16208377. S2CID   4355750.
  14. ↑ Kimbrough TG, Miller SI (September 2000). "Contribution of Salmonella typhimurium type III secretion components to needle complex formation". Proceedings of the National Academy of Sciences of the United States of America. 97 (20): 11008–11013. Bibcode:2000PNAS...9711008K. doi: 10.1073/pnas.200209497 . PMC   27139 . PMID   10984518.
  15. ↑ YashRoy RC (2003). "Eucaryotic cell intoxication by gram-negative pathogens: A novel bacterial outermembrane-bound nanovesicular exocytosis model for Type III secretion system". Toxicology International. 10 (1): 1–9.
  16. ↑ Zychlinsky A, Kenny B, Ménard R, Prévost MC, Holland IB, Sansonetti PJ (February 1994). "IpaB mediates macrophage apoptosis induced by Shigella flexneri". Molecular Microbiology. 11 (4): 619–627. doi:10.1111/j.1365-2958.1994.tb00341.x. PMID   8196540. S2CID   40167923.
  17. ↑ Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, et al. (December 1998). "Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB". The Journal of Biological Chemistry. 273 (49): 32895–32900. doi: 10.1074/jbc.273.49.32895 . PMID   9830039.
  18. ↑ Boch J, Bonas U (2010). "Xanthomonas AvrBs3 family-type III effectors: discovery and function". Annual Review of Phytopathology. 48: 419–436. doi:10.1146/annurev-phyto-080508-081936. PMID   19400638.
  19. ↑ Moscou MJ, Bogdanove AJ (December 2009). "A simple cipher governs DNA recognition by TAL effectors". Science. 326 (5959): 1501. Bibcode:2009Sci...326.1501M. doi:10.1126/science.1178817. PMID   19933106. S2CID   6648530.
  20. ↑ Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, et al. (December 2009). "Breaking the code of DNA binding specificity of TAL-type III effectors". Science. 326 (5959): 1509–1512. Bibcode:2009Sci...326.1509B. doi:10.1126/science.1178811. PMID   19933107. S2CID   206522347.
  21. ↑ Schraidt O, Lefebre MD, Brunner MJ, Schmied WH, Schmidt A, Radics J, et al. (April 2010). Stebbins CE (ed.). "Topology and organization of the Salmonella typhimurium type III secretion needle complex components". PLOS Pathogens. 6 (4): e1000824. doi: 10.1371/journal.ppat.1000824 . PMC   2848554 . PMID   20368966.
  22. ↑ Grynberg M, Godzik A (April 2009). Stebbins CE (ed.). "The signal for signaling, found". PLOS Pathogens. 5 (4): e1000398. doi: 10.1371/journal.ppat.1000398 . PMC   2668190 . PMID   19390616.
  23. ↑ Yu XJ, McGourty K, Liu M, Unsworth KE, Holden DW (May 2010). "pH sensing by intracellular Salmonella induces effector translocation". Science. 328 (5981): 1040–1043. Bibcode:2010Sci...328.1040Y. doi:10.1126/science.1189000. hdl:10044/1/19679. PMC   6485629 . PMID   20395475.
  24. ↑ Medini D, Covacci A, Donati C (December 2006). "Protein homology network families reveal step-wise diversification of Type III and Type IV secretion systems". PLOS Computational Biology. 2 (12): e173. Bibcode:2006PLSCB...2..173M. doi: 10.1371/journal.pcbi.0020173 . PMC   1676029 . PMID   17140285.
  25. 1 2 Saier MH (March 2004). "Evolution of bacterial type III protein secretion systems". Trends in Microbiology. 12 (3): 113–115. doi:10.1016/j.tim.2004.01.003. PMID   15001186.
  26. ↑ McCann HC, Guttman DS (2008). "Evolution of the type III secretion system and its effectors in plant-microbe interactions". The New Phytologist. 177 (1): 33–47. doi: 10.1111/j.1469-8137.2007.02293.x . PMID   18078471.
  27. ↑ Abby SS, Rocha EP (September 2012). "The non-flagellar type III secretion system evolved from the bacterial flagellum and diversified into host-cell adapted systems". PLOS Genetics. 8 (9): e1002983. doi: 10.1371/journal.pgen.1002983 . PMC   3459982 . PMID   23028376.
  28. ↑ Moran NA (February 2001). "Bacterial menageries inside insects". Proceedings of the National Academy of Sciences of the United States of America. 98 (4): 1338–1340. Bibcode:2001PNAS...98.1338M. doi: 10.1073/pnas.98.4.1338 . PMC   33380 . PMID   11171951.
  29. 1 2 Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, et al. (April 1998). "Supramolecular structure of the Salmonella typhimurium type III protein secretion system". Science. 280 (5363): 602–605. Bibcode:1998Sci...280..602K. doi:10.1126/science.280.5363.602. PMID   9554854.
  30. ↑ Cordes FS, Komoriya K, Larquet E, Yang S, Egelman EH, Blocker A, Lea SM (May 2003). "Helical structure of the needle of the type III secretion system of Shigella flexneri". The Journal of Biological Chemistry. 278 (19): 17103–17107. doi: 10.1074/jbc.M300091200 . PMID   12571230.
  31. ↑ Marlovits TC, Kubori T, Sukhan A, Thomas DR, Galán JE, Unger VM (November 2004). "Structural insights into the assembly of the type III secretion needle complex". Science. 306 (5698): 1040–1042. Bibcode:2004Sci...306.1040M. doi:10.1126/science.1102610. PMC   1459965 . PMID   15528446.
  32. ↑ Sani M, Allaoui A, Fusetti F, Oostergetel GT, Keegstra W, Boekema EJ (2007). "Structural organization of the needle complex of the type III secretion apparatus of Shigella flexneri" (PDF). Micron. 38 (3): 291–301. doi:10.1016/j.micron.2006.04.007. hdl: 11370/9ee8c380-a931-4313-89cf-d9faa49cdf3b . PMID   16920362.
  33. ↑ Hodgkinson JL, Horsley A, Stabat D, Simon M, Johnson S, da Fonseca PC, et al. (May 2009). "Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout". Nature Structural & Molecular Biology. 16 (5): 477–485. doi:10.1038/nsmb.1599. PMC   2681179 . PMID   19396171.
  34. ↑ Zhang L, Wang Y, Picking WL, Picking WD, De Guzman RN (June 2006). "Solution structure of monomeric BsaL, the type III secretion needle protein of Burkholderia pseudomallei". Journal of Molecular Biology. 359 (2): 322–330. doi:10.1016/j.jmb.2006.03.028. PMID   16631790.
  35. ↑ Deane JE, Roversi P, Cordes FS, Johnson S, Kenjale R, Daniell S, et al. (August 2006). "Molecular model of a type III secretion system needle: Implications for host-cell sensing". Proceedings of the National Academy of Sciences of the United States of America. 103 (33): 12529–12533. Bibcode:2006PNAS..10312529D. doi: 10.1073/pnas.0602689103 . PMC   1567912 . PMID   16888041.
  36. ↑ Galkin VE, Schmied WH, Schraidt O, Marlovits TC, Egelman EH (March 2010). "The structure of the Salmonella typhimurium type III secretion system needle shows divergence from the flagellar system". Journal of Molecular Biology. 396 (5): 1392–1397. doi:10.1016/j.jmb.2010.01.001. PMC   2823972 . PMID   20060835.
  37. 1 2 Loquet A, Sgourakis NG, Gupta R, Giller K, Riedel D, Goosmann C, et al. (May 2012). "Atomic model of the type III secretion system needle". Nature. 486 (7402): 276–279. Bibcode:2012Natur.486..276L. doi:10.1038/nature11079. PMC   3598588 . PMID   22699623.
  38. ↑ Holmes TC, May AE, Zaleta-Rivera K, Ruby JG, Skewes-Cox P, Fischbach MA, et al. (October 2012). "Molecular insights into the biosynthesis of guadinomine: a type III secretion system inhibitor". Journal of the American Chemical Society. 134 (42): 17797–17806. doi:10.1021/ja308622d. PMC   3483642 . PMID   23030602.
  39. ↑ Theuretzbacher U, Piddock LJ (July 2019). "Non-traditional Antibacterial Therapeutic Options and Challenges". Cell Host & Microbe. 26 (1): 61–72. doi: 10.1016/j.chom.2019.06.004 . PMID   31295426.
  40. ↑ Pylkkö T, Ilina P, Tammela P (May 2021). "Development and validation of a high-content screening assay for inhibitors of enteropathogenic E. coli adhesion". Journal of Microbiological Methods. 184: 106201. doi: 10.1016/j.mimet.2021.106201 . PMID   33713725.
  41. ↑ Kimura K, Iwatsuki M, Nagai T, Matsumoto A, Takahashi Y, Shiomi K, et al. (February 2011). "A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium". The Journal of Antibiotics. 64 (2): 197–203. doi: 10.1038/ja.2010.155 . PMID   21139624.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.